KPV

Research

KPV (Lysine-Proline-Valine)

Aliases
alpha-MSH fragment
Administration
Subcutaneous injection (research), Oral (research), Topical (research)

Documented benefits

Tier 1 · Peer-reviewed / regulatory

Benefit categories

Immune & Inflammatory

KPV's defining research application — the smallest active fragment of alpha-MSH, isolated specifically for its anti-inflammatory activity.

Anti-inflammatory

Blocks the NF-κB inflammatory pathway directly, a more targeted mechanism than BPC-157's broader angiogenic approach.

Gut lining restoration

Extensively studied in rodent models of colitis specifically, a narrower focus than BPC-157's broader gut-healing research.